A preliminary review of side effects from popular drugs used to treat diabetes and obesity shows no link with suicidal thoughts or actions, the U.S. Food and Drug Administration said Thursday. But the agency also said officials cannot definitively rule out that “a small risk may exist" and that they'll continue to look into reports regarding more than a dozen drugs, including Ozempic, Wegovy and Mounjaro. Patients taking the drugs should report any concerns to health care providers, the FDA said.